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Abstract 
Through research carried out in the last 25 years about the breast cancer etiology, it has been possible to estimate 
that less than 10 % of patients who are diagnosed with the condition are carriers of some germline or somatic muta‑
tion. The clinical reports of breast cancer patients with healthy twins and the development of disease in women 
without high penetrance mutations detected, warn the participation more factors in the transformation process. The 
high incidence of mammary adenocarcinoma in the modern woman and the urgent need for new methods of pre‑
vention and early detection have demanded more information about the role that environment and lifestyle have on 
the transformation of mammary gland epithelial cells. Obesity, alcoholism and smoking are factors that have shown a 
close correlation with the risk of developing breast cancer. And although these conditions affect different cell regula‑
tion levels, the study of its effects in the mechanisms of transcriptional and epigenetic regulation is considered critical 
for a better understanding of the loss of identity of epithelial cells during carcinogenesis of this tissue. The main 
objective of this review was to establish the importance of changes occurring to transcriptional level in the mammary 
gland as a consequence of acute or chronic exposure to harmful products such as obesity‑causing foods, ethanol and 
cigarette smoke components. At analyze the main studies related to topic, it has concluded that the understanding of 
effects caused by the lifestyle factors in performance of the transcriptional mechanisms that determine gene expres‑
sion of the mammary gland epithelial cells, may help explain the development of this disease in women without 
genetic propensity and different phenotypic manifestations of this cancer type.
Resumen 
A través de la investigación realizada en los últimos 25 años en torno a la etiología del cáncer de mama, ha sido 
posible estimar que menos del 10 % de las pacientes que son diagnosticadas con la enfermedad son portadoras de 
alguna mutación de línea germinal o somática. Los informes clínicos de pacientes de cáncer de mama con gemelas 
saludables y el desarrollo de la enfermedad en las mujeres sin mutaciones de alta penetrancia detectadas, advierten 
la participación de otros factores en el proceso de transformación. La alta incidencia de adenocarcinoma de mama en 
la mujer moderna y la necesidad urgente de nuevos métodos para la prevención y detección temprana han exigido 
una mayor información en relación al papel que el medio ambiente y el estilo de vida tienen en la transformación 
de las células epiteliales de la glándula mamaria. La obesidad, el alcoholismo y el tabaquismo son factores que han 
demostrado una estrecha correlación con el riesgo de desarrollar cáncer de mama. Y aunque estas condiciones 
pueden afectar distintos niveles de regulación celular, el estudio de sus efectos en los mecanismos de regulación 
transcripcional y epigenética, es considerado fundamental para un mayor entendimiento de la pérdida de identidad 
de las células epiteliales durante la carcinogénesis de este tejido. El objetivo principal de esta revisión fue establecer la 
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Background
The ethnic and regional variations reported in the inci-
dence of breast cancer, as well as the sustained increase 
in the number of cases that this disease has since the 
80s to date, are some topics that can not be explained 
solely in function of inherited or acquired mutations in 
high penetrance genes [1]. Epidemiological studies have 
reported a positive correlation between increased risk 
of breast cancer and the growing consumption of high-
fat foods, ethanol and tobacco by current women [2]. 
This has prompted a further research of the molecular 
mechanisms underlying the appearance of breast can-
cer by some habits that women have been adopting their 
lifestyle.
The oncogenic pathologies are currently considered 
the result of the loss of cell identity caused by the distur-
bance in expression of proteins associated with the cell 
differentiation. Among the multiple factors that can alter 
gene expression programs, the high penetrance muta-
tions, inherited or acquired, are the most easily detect-
able causes. However, the percentage of breast cancer 
cases etiologically associated with this type of mutations 
does not exceed 10 % [3, 4]. The high probability of devel-
oping cancer from these mutations is explained by the 
fact that the affected genes, encode proteins involved in 
cellular processes such as: DNA repair, cell cycle regula-
tion and protection against xenobiotics and free radicals, 
which are essential functions for maintaining the fidel-
ity and integrity of the genome [4]. In the case of breast 
cancer, genetic linkage analysis and next generation 
sequencing studies have found that higher penetrance 
mutations occur mainly in the genes encoding: breast 
cancer 1 (BRCA1), tumor protein p53 (TP53), phosphati-
dylinositol-4,5-bisphosphate 3-kinase catalytic subunit 
alpha (PIK3CA), retinoblastoma 1 (RB1), phosphatase 
and tensin homolog (PTEN), GATA binding protein 3 
(GATA-3) and mitogen-activated protein kinase kinase 
kinase 1 (MAP3K1) [5–7]. Such modifications com-
monly alter the open reading frame of the gene, result-
ing in the loss or gain of function in the encoded proteins 
[4]. However, the involvement of mutations in regions of 
gene transcriptional regulation, and its association in the 
development of breast cancer needs further investigation.
On the other hand, the association that the epidemiol-
ogy studies have found between the process of cell malig-
nancy and some lifestyle factors such as smoking, diet, 
alcoholism and obesity; has prompted a further research 
on the role of alterations produced by these factors in the 
mechanisms of gene expression regulation [2]. Although 
there are several regulation levels for the gene expression, 
the transcriptional regulation mechanisms are consid-
ered the fundamental system whereby the cells can mod-
ulate, halt or activate the expression of a given gene [8]. 
So that any malfunction or modification in the expression 
of the proteins involved in these mechanisms could have 
important consequences in the cell protein expression.
Relationship between lifestyle risk factors and breast 
cancer
The molecular biology studies have provided evidences 
for cancer etiology and now it is known that genetic 
mutations occur constantly and naturally in the cells, as 
a collateral consequence of the processes of recombina-
tion, replication and cell metabolism [9, 10]. There are 
enzymatic systems responsible for the prevention, repair 
and correction of damage or errors caused for the normal 
cell operation. However, in cancer cells the stress induced 
by disease itself or by external factors can increase the 
mutation frequency, since protection and proofreading 
systems are overcome by high free radical levels char-
acteristic of these conditions [3, 11]. Certain chemical 
agents, ionizing radiations and even poorly balanced 
diets are currently considered risk factors that may con-
tribute to cancer development [11, 12]. These factors can 
induce cell proliferation, survival and metastasis through 
either gene mutations on the proteins responsible for cell 
protection and maintenance, or by its molecular interac-
tion with proteins involved in transcriptional regulation 
mechanisms [13].
One explanation to the increase in the incidence of 
breast cancer it has been based precisely on the grow-
ing trend of women to adopt certain consumption habits, 
importancia de los cambios que ocurren a nivel transcripcional en la glándula mamaria, como consecuencia de una 
exposición aguda o crónica a productos nocivos, tales como los alimentos que favorecen la obesidad, el etanol y los 
componentes del humo del cigarro. Al analizar los principales estudios relacionados con el tema, se ha llegado a la 
conclusión de que la comprensión de los efectos causados por los factores de estilo de vida sobre el desempeño de 
los mecanismos de regulación transcripcional responsables de la expresión génica de las células epiteliales de la glán‑
dula mamaria, pueden ayudar a explicar el desarrollo de esta enfermedad en las mujeres que no son genéticamente 
propensas así como las diferentes manifestaciones fenotípicas de este tipo de cáncer.
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such as the high-fat diets, uptake of alcoholic beverages 
and tobacco, which are risk factors for this illness [13]. 
The overconsumption of fat foods, for example, increases 
both the hyperplasia and hypertrophy of adipose tissue. 
This tissue is the main producer of estrogens in post-
menopausal women, so that their uncontrolled growth 
leads to greater exposure than normal to estrogens dur-
ing the life of the woman. The contribution of these hor-
mones on cell proliferation increases the probability that 
those cells carrying high penetrance mutations thrive 
within the mammary gland [14–16].
On the other hand, the acetaldehyde is the main catab-
olite of the ethanol metabolism in humans and has been 
classified as a carcinogen by the International Agency 
for Research on Cancer [17]. This compound is capable 
of forming adducts with DNA, promoting the process of 
mutagenesis and cell malignancy [18]. In addition, clini-
cal studies have reported a correlation between moderate 
ethanol intake (15–30 g/day) and increased risk of breast 
cancer in the premenopausal women group homozygous 
for the alcohol dehydrogenase 31 alelle (ADH31−1); phe-
notype that be characterize by an activity increased of 
alcohol dehydrogenase and thus a major production of 
acetaldehyde from ethanol [19].
Regarding the role of smoking on carcinogenesis in the 
breast tissue; some clinical and epidemiological studies 
have found a strong correlation between women with 
active exposure to tobacco smoke and breast cancer 
incidence [20, 21]. Furthermore, the presence of vari-
ous chemicals generated by the cigarette combustion, 
have been detected in mammary gland tissue of healthy 
women and breast cancer patients [22–24]. On the other 
hand, evidence from in  vitro studies suggest that vari-
ous substances from the cigarette smoke such as nicotine 
[25], benzo(a)pyrene [26], 1-methylanthracene [27] and 
phenanthrene [28] may to provoke alterations in epige-
netic and transcriptional mechanisms which regulates 
the expression of genes involved in transformation of 
healthy epithelial cells as well as proliferation and metas-
tasis of tumor epithelial cells into the mammary gland.
Transcriptional regulation in breast cancer
The progressive loss of cell morphology and function are 
events that commonly occurs among the different types 
of cancer, as a consequence of the drastic changes in gene 
expression of cells affected during the disease develop-
ment. However, studies performed in reference to the 
etiology underlying to cancer, indicate that triggering 
causes of this transformation are diverse and may have 
an epigenetic, genetic or post-translational origin [29]. 
These alterations can affect the expression or function of 
certain proteins, such as transcription factors, co-regu-
lators, histones, as well as enzymes that modify histones 
and DNA; each of which play a specific role in the mech-
anisms of transcriptional regulation [3, 30, 31].
The overexpression and gene amplification of tran-
scription factors, such as estrogen receptor alpha (ERα) 
[31], avian myelocytomatosis viral oncogene homologue 
factor (c-myc) [32] are among first alterations of the tran-
scriptional regulation mechanisms that were found asso-
ciated to development of breast cancer. At present, due to 
its role in proliferation of the mammary adenocarcinoma 
cells, are considered key oncoproteins for diagnosis for 
this pathology. Conversely, tumor suppressor proteins, 
such as retinoblastoma protein (Rb) [33] and p53 [32], 
are common targets of different mutation events that 
eliminate the repressive function of these transcription 
factors over genes associated with the replication and cell 
division in malignant breast tumors.
Several research lines have provided evidence of that 
a select group of transcriptional regulators, termed as 
“Master”, work together in the trans-activation of critical 
genes for maintaining of plasticity and unlimited propa-
gation that characterize to the embryonic stem cells [29, 
30, 34]. However, it has also been reported that oth-
ers cell types differenced or malignant, also have a cell-
specific repertory of Master transcription factors that 
defines its gene expression scheme. Even recently been 
shown that Master factors can exercise its transcriptional 
activity on cell-identity genes or oncogenes, through its 
interaction with the Mediator multiprotein coactivator 
and regulation regions sets, known as Super-enhancers 
[29, 35]. This new mechanism increases stability and pro-
cessivity of the general transcription machinery, thereby 
increasing the transcription of target genes. These find-
ings confirm the crucial role that transcriptional control 
mechanisms have in the cellular changes during develop-
ment, as well as the vulnerability of these same mecha-
nisms to the alterations that trigger the transformation of 
healthy cells to malignant cells.
Recent analyzes of reporter activity arrays of transcrip-
tion factors in different breast cancer-derived cell lines, 
have found more specifically that Master factors Twist, 
Snail, Slug and E47 are involved in the establishment of 
some phenotypic processes, such as epithelial-mesen-
chymal transition and metastasis [36, 37]. Furthermore, 
Martin and colleagues have found previously a correla-
tion between increased expression of these Master fac-
tors and breast cancer tumors with metastasis or poor 
prognosis [38]. In addition it has also shown that these 
same factors may repress the transcription of gene CDH1 
encoding cadherin-1 (Cadh-1), through the interaction 
of its C2H2 type zinc finger domain with E boxes located 
within promoters regulating the expression of this pro-
tein that is important for adhesion and polarity of mam-
mary gland epithelial cells [39].
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Regarding the role of Super-enhancers in development 
of breast cancer, it has been reported that the oncogenes: 
human epidermal growth receptor 2 (ERBB2), hepato-
cyte growth factor receptor (MET), MYC, nuclear recep-
tor coactivator A3 (NCOA3), neurogenic locus notch 
homolog protein 2 (NOTCH2) and Runt-related tran-
scription factor 1 (RUNX1) are part of specific expression 
scheme that is induced by this new regulatory regions for 
the acquisition of the malignant phenotype [30]. Impor-
tantly, the last four genes encode proteins with functions 
closely associated with the regulation of transcription. 
This suggests that the identity of the breast cancer cells 
could be controlled by an hierarchical regulation organi-
zation in where the top of the pyramid is occupied by 
Master transcription factors that trans-activate the 
expression of other factors of lower hierarchy but with a 
higher cellular specificity; that in turn regulate the tran-
scription of genes involved in the expression of the final 
phenotypic characteristics.
Effects of obesity in transcriptional regulation
Evidence of the proliferative effect that obesity has in 
health and malignant epithelial cells in the mammary 
gland is extensive. It is known that this effect is due to 
an imbalance in levels of adipose-derived hormones to 
regulate the energy metabolism [40–43]. During the 
post-menopause, women stop the production of ovarian 
estrogen, leaving to the adipose tissue as the main sup-
plier of this hormone. When the energy reserves exceed 
the storage capacity of this tissue, the adipocytes undergo 
both hyperplasia and hypertrophy which result in 
increased levels of Leptin, one major hormones produced 
by adipocytes that travel through the bloodstream to the 
hypothalamus to induce the satiety signal. However, it 
is known that the leptin receptor (Ob-R) is expressed in 
other cell types, such as the adipose derived stromal cells 
(ADSCs) and epithelial cells of the mammary gland; in 
where the leptin acts in paracrine and autocrine way for 
the induction of several signaling pathways converging 
in the induction of cell proliferation [44]. For purposes 
of this review, will be addressed three of these pathways, 
which exemplify widely the relevance of the transcrip-
tional regulation mechanisms in the development of 
malignant tumors in the mammary gland (Fig. 1).
The ADSCs are an adipose tissue cell type with the 
capacity to synthesize and secrete 17-β estradiol (E2) 
through enzymatic aromatization of δ-4-androstenedione 
(δ4A) by cytochrome P450 aromatase (CP450Arom). 
Because of the importance of the E2 in activation of sev-
eral genes of cell proliferation, it is considered that the 
transactivation of cytochrome P450, family 19, subfam-
ily A (CYP19A) gene, is a critical control point for the 
formation and survival of malignant tumors expressing 
estrogen receptor alpha (ERα) [45]. One mechanism con-
sidered as key to the aromatase mRNA expression is the 
recruitment of cAMP response element binding protein 
(CREB) to the proximal promoter of CYP19A (called 
PII). For CREB to carry out the CYP19A transactivation, 
this transcription factor must first bind one of its main 
coactivators, the CREB regulated transcription coactiva-
tor (CRTC) [40]. The nuclear translocation and activity of 
the CRTC is in turn modulated by phosphorylation of its 
Ser-171 residue via adiponectin receptor (AdipoR)/liver 
kinase B1 (LKB1)/AMP activated protein kinase (AMPK) 
signaling pathway. Adiponectin is other adipokine that 
under physiological conditions its serum concentration is 
higher than leptin, allowing modulate to the CP450Arom 
and E2 levels in ADSCs [46]. Conversely, the uncon-
trolled secretion of leptin caused by obesity, inhibits the 
phosphorylation of CRTC through Ob-R, increasing thus 
the CP450Arom expression and local production of E2 
(Fig.  1). Consequently, the increase of E2 levels in the 
mammary gland, amplifies the expression of genes asso-
ciated with cell proliferation in breast ductal epithelium 
[41].
On the other hand, in the mammary gland epithelial 
cells, leptin stimulate the production of Cadh-1, a pro-
tein that is used by the epithelial cells for the formation 
of adherent junctions (Fig.  1). The role of Cadh-1 has 
been experimentally correlated, with both growth of 
early primary breast carcinoma and metastasis suppres-
sion of most advanced tumors [47]. In addition, others 
in vitro studies have found that the interaction of leptin 
with Ob-R activates the extracellular signal-regulated 
protein kinases (ERKs) pathway, which in turn induces 
the nuclear translocation and binding of CREB and ERα 
to cAMP response element (CRE) and specific protein 1 
(SP1), respectively, in the CDH1 promoter [48]. Leptin-
induced interaction between ERα and SP1 is independ-
ent of E2, so that can be inferred that leptin enhances the 
non-classical genomic pathway of ER in the transcrip-
tional activation mechanism of Cadh-1 [49].
Studies in cell lines derived from breast cancer have 
shown that malignant epithelial cells, also induces 
expression functional of CP450Arom through leptin and 
its receptor [41–43]. Although the mechanism of tran-
scriptional activation of CYP19A in malignant cells is 
not completely understood, it is known that the CYP19A 
promoter is transactivated through its cis-element for 
activating protein 1 (AP1) in the cell line derived from 
breast cancer MCF 7 (Fig.  1). Electrophoretic mobility 
shift assays in the presence of leptin suggest that the tran-
scription factor AP-1 could be activated through phos-
phorylation of mitogen activated protein kinase (MAPK) 
and/or the ERKs. Likewise, it was showed the involve-
ment of signal transducer and activator of transcription 3 
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(STAT3) in transactivation of the AP-1 element, although 
it is still unknown at what level of mechanism this is 
involved [41]. Together these data indicate that leptin 
may induce directly E2-dependent cell proliferation of 
malignant epithelial cells in the mammary gland, through 
an alternative route that has not been fully investigated.
Effects of alcoholism in transcriptional regulation
The positive correlation that the epidemiological studies 
have found between moderate or chronic ethanol con-
sumption and the incidence of breast cancer in pre- and 
post-menopausal women indicates the importance that 
environmental factors have in the development of this 
pathology [50–52]. Alcoholism, like other environmen-
tal risk factors, may cause alterations in gene expression 
through different pathways. Ethanol concentrations as 
low as 0.06 % have effect in the transcriptional expression 
of genes related with malign proliferation of mammary 
gland epithelial cells [53, 54]. Due to this characteristic it 
was considered relevant to review the molecular mecha-
nisms through which the ethanol exerts its activity and 
influences the transcriptional regulation.
Because about 75 % of breast cancer patients are ERα-
positive and the contribution of ethanol in estrogen-
dependent induction of cellular proliferation, survival 
and metastasis [54, 55] has been demonstrated, the 
mechanisms underlying the increase of ethanol-induced 
estrogen activity have gained interest in both clinical 
and basic research. As previously mentioned, the over-
expression of CP450Arom and ERα is usually critical to 
early development of mammary adenocarcinoma [53, 
56]. In vitro studies have shown that moderate doses of 
ethanol induce the synthesis of ERα mRNA and the pro-
liferation of breast cancer cells; however, the complete 
mechanism of transcriptional regulation remains elusive.
On the other hand, the investigation of the effects of 
ethanol upstream of the CP450Arom transcription found 
that acute and chronic exposure to ethanol concentra-
tions above 0.5 % provides a greater stability to adenylyl 
cyclase (AC), blocks the Gαi function and promotes an 
irregular increase in cAMP production [54, 57–59]. This 
increase in cAMP levels in turn promotes the transac-
tivation of target genes for CREB, such as CP450Arom 
[53] and the mitogen agonist belonging to the endothelial 
Fig. 1 Scheme of molecular mechanisms that obesity can influence during carcinogenesis of the mammary gland. The abnormal increase of leptin 
levels in obesity is an event which can positively regulate transcription of genes associated with tumor growth and proliferation such as Cadh‑1 and 
CP450Arom, respectively. Solid lines indicate a mechanism or pathway established experimentally. Dashed lines indicate a mechanism or pathway 
not determined yet. Arrowheads indicate upregulation and flattened heads indicate downregulation
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growth factor family, Amphiregulin (Amph) [48, 60, 
61]. In breast cancer, it has been reported two coupling 
alternate routes of the E2 synthesis with EGFR signal-
ing (Fig.  2). The first and most widely described is the 
ERα-dependent transcriptional activation pathway for 
the Amph and TGFα expression [60, 62–64]. Secondly, is 
the overstimulation of EGFR signaling pathways through 
membrane-bound classic estrogen receptors or G protein 
coupled estrogen receptor, which activate to the metal-
loproteinases responsible for release of EGFR agonists 
anchored to the cell membrane [65, 66]. There is also 
evidence obtained from a study of the breast cancer sign-
aling pathways, which indicate that EGFR can induce to 
the ligand-independent and dependent activity of ERα 
by means of the protein kinase A (PKA) and inhibitor of 
kappaB kinase α (IKKα) phosphorylation, respectively, 
thereby closing the positive feedback loop [67, 68].
The existing bidirectional feedback between EGFR 
signaling and estrogenic activity is essential for the pres-
ervation of malignant phenotype in the breast cancer 
cells; since both pathways converge in the transactivation 
of genes correlated with the tumor proliferation, survival, 
aggressiveness; such as MYC [69, 70], B cell lymphoma 
2-like protein (Bcl-XL) [71, 72], cyclin D1 (CCND1) [73, 
74], cyclin-dependent kinase inhibitor A1 (CDKN1A) 
[75, 76] and the subunits that integrate the activator 
protein 1 (AP1) [77, 78]. However, recent studies of cell 
migration performed in the cell line of breast cancer 
MCF-7 have reported that ethanol, unlike to mechanism 
induced by leptin in obesity, can cause increased cell 
migration at a concentration of 12 %, an effect that was 
correlated mainly with a decrease in the expression of the 
Cadh-1 [48, 61]. Although not known for sure the mech-
anism by which ethanol inhibits expression of Cadh-1, 
there is evidence of recruitment of Master repressor fac-
tors, Snail and Slug, to the CDH1 promoter in breast can-
cer cells (Fig. 2). These two factors are activated directly 
or indirectly by ERK, AKT and p38; which are targets 
of EGFR activity [79]. So it would be very important to 
establish experimentally whether ethanol is involved in 
this mechanism to promote cell migration.
Furthermore, the repression of ER transcriptional 
activity by the interaction with BRCA1 is another event 
considered critical in the control of the mammary ade-
nocarcinoma cells proliferation [80–82]. With the aim 
of determine if ethanol has any effect in this mecha-
nism, it has recently been analyzed the mRNA and pro-
tein expression of both factors in ERα-negative cell lines 
Fig. 2 Scheme of the molecular mechanisms that ethanol consumption can influence during carcinogenesis of the mammary gland. Trace 
amounts of ethanol can promote transcription of CP450Arom, ERα and some EGFR agonists, which in turn favor the progress and survival of breast 
cancer cells. Acute exposure to ethanol can also negatively interfere the transcriptional regulation of genes that prevent the proliferation and 
spread of breast cancer, such as BRCA1 and Cadh‑1. Solid lines indicate a mechanism or pathway established experimentally. Dashed lines indicate a 
mechanism or pathway not determined yet. Arrowheads indicate upregulation and flattened heads indicate downregulation
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and human epidermal growth factor receptor 2 (HER2)-
positive mice tumors under treatment of increasing con-
centrations of ethanol. The results showed that under 
these conditions (Fig. 2), ERα levels increase in a dose–
response way with respect to controls without treatment, 
while the BRCA1 levels decrease inversely proportional 
to the ethanol dose [80]. Furthermore, it was found that 
these alterations in the expression of both proteins are 
closely correlated with cell proliferation promoted by 
ethanol [55]. Although these results suggest the direct 
participation of ethanol on the transcriptional regulation 
mechanisms of genes encoding to ERα and BRCA1, fur-
ther research is need.
Several clinic and epidemiological studies performed 
in humans and other mammalians suggest that some 
chronic disorders elicited by ethanol abuse, such as 
hepatosteatosis [83], megaloblastic anemia [84], pan-
creatic disorders [85] and certain cancers [66], are clini-
cally associated with a systemic deficiency of folate. It has 
been shown that ethanol can interfere both the absorp-
tion and assimilation of this vitamin, thus affecting the 
normal synthesis of methionine by organism cells [86, 
87]. This insufficiency in the methionine requirements 
induces a reprogramming on the genome activity, caus-
ing the expression of oncogenes in the cells [83, 88, 89]. 
Although this same mechanism has been implicated by 
some authors in the ethanol-induced rehabilitation of 
ERα expression in breast cancer [90], more molecular 
studies to support this idea are required. On the other 
hand, it has been shown that ethanol-induced global 
hypomethylation can alter both the expression and 
activity of DNA methyltransferases during carcinogen-
esis. This mechanism has been involved in the ethanol-
induced specific hypermethylation of tumor suppressor 
genes [91]. However, the possibility that this mechanism 
explain the BRCA1 silencing observed in breast cancer 
cells treated with ethanol, not yet been explored.
Effects of smoking in transcription regulation
Due to the large amount of compounds generated from 
the cigarette combustion, the search concerning the eti-
ology and causal agents of breast cancer associated with 
smoking has been difficult. As mentioned previously, 
many of the effects caused by the tobacco are attributed 
to somatic mutations produced by adducts formed in 
genes of high penetrance that lead to cell malignancy. 
However, in  vitro studies focused on gene expres-
sion changes between tumor and healthy cells from the 
mammary gland epithelium exposed to cigarette smoke 
extract (CSE); have shown that a large number of genes 
are regulated either positively or negatively. Nonethe-
less, the reproducibility of each phenotype obtained, 
even those with significant changes, was low [92]. Among 
the genes that were found with significant changes in 
expression, only ocludin and claudin-1 had an increase 
in its methylation; which is consistent with the previously 
observed significant decrease in their levels of mRNA and 
protein after CSE treatment. Additionally, it was found 
that the gene encoding estrogen receptor beta (ERβ) also 
had a higher methylation after CSE treatment [92]; which 
agrees with others reports of tumor suppression by this 
receptor [93, 94]. However, the specific compound in cig-
arette smoke and the mechanism through which triggers 
methylation and therefore epigenetic silencing of these 
genes, is still unknown.
The transcriptional mechanisms that mediate the 
transformation and survival of malignant breast cells as a 
result of smoking have been studied. Connors et al., pro-
vided evidence supporting the participation of transcrip-
tion factor CCAAT element binding protein beta (C/
EBPβ), in the transactivation of anti-apoptotic gene Bcl-
XL [95]. It is well established that the protein encoded 
by this gene is actively involved in the suppression of 
apoptotic caspase pathway (Fig.  3), and it is currently 
used as a marker of migration and tumor aggressiveness 
[96]. The exposure of non-malignant MCF-10A cell line 
to increasing concentrations of a cigarette smoke con-
densate (CSC) resulted in a rising in the expression of 
both mRNA and protein of Bcl-XL. It was further deter-
mined that the CSC simultaneously induces the C/EBPβ 
expression; which in turn interacts functionally with its 
cis-element in the Bcl-XL, and promotes thus the tran-
scriptional activity in this gene [95]. Although the mech-
anism by which cigarette smoke increases C/EBPβ levels 
in these cells is not known yet, it is clear that smoking 
may induce the survival and aggressiveness of breast epi-
thelial cells with high penetrance mutations.
Another molecular model that explain the relationship 
between the phenotypic features of breast tumor cells 
and smoking, was also partially solved from the nicotine 
effects in the transcriptional regulation Bcl-2 and the 
cell cycle-regulatory CDC25A phosphatase (Fig.  3). The 
nicotine is a compound of the cigarette smoke composi-
tion and was found to interact with the ionotrópic ace-
tylcholine receptor (AChR) of nerve cells [97]. However, 
it has been reported that epithelial cells of others tissues 
also express the AChR for nicotine [98–100]. Assays 
performed in the cell lines MCF-10A and MDA-MB231 
demonstrated that the nicotine may induce the simulta-
neous activity of ERKs and protein kinase B (PKB) by a 
crosstalk between the nicotinic AChR and EGFR, where 
the Scr kinase performs the connection. The ERKs path-
way culminates in the phosphorylation of E2F1, which 
is a highly specific transcription factor of gene encoding 
CDC25A. On the other hand, the PKB phosphorylation 
pathway is responsible for inducing the transcriptional 
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expression of Bcl-2, although it is unknown the cis-ele-
ments or factors involved [101].
Conclusion
The research conducted around the identification of 
high penetrance mutations through the recent massive 
sequencing technologies, has facilitated the identifica-
tion of target genes associated with each type of cancer. 
However, the etiologic contribution of genetic altera-
tions to cancer development represents barely one-tenth 
of all possible causes [102]. In the case of breast cancer, 
several environmental and lifestyle factors have already 
been correlated with this disease through meta-analysis 
[1]; which has helped to narrow the search for the mech-
anisms involved at the molecular level in the transfor-
mation of the epithelial cells or tumor progression into 
mammary gland.
Much of the effects caused by main risk factors of life-
style are associated in some way with estrogen-dependent 
molecular mechanisms that induce the proliferation and 
survival of cells in the breast cancer. However, in the par-
ticular case of tobacco, although the correlation between 
abusive consumption of this product and estrogen levels 
in post-menopausal women is well established [103], the 
mechanism by which this habit could be altering estrogen 
synthesis are still unknown. On the other hand, the inves-
tigation of estrogen-dependent molecular mechanisms 
that are altered by systematic intake of ethanol and fatty 
acids during malignant transformation in the mammary 
gland, has achieved an improvement in providing the 
fundaments that will allow a better understanding of the 
disease for further prevention and treatment.
The biological activity of acute or chronic consumption 
of fatty acids, ethanol and cigarette smoke, has been func-
tionally linked to transcriptional processes that regulate 
the gene expression patterns of target cells in the mam-
mary gland through leptin, EGFR family agonists and nic-
otine, respectively. However, it is important to note that 
some events such as leptin-dependent transactivation of 
CYP19A in breast cancer cells, changes induced by etha-
nol in transcriptional expression of ERα and BRCA1, and 
nicotine-dependent transcriptional induction of Bcl-2 are 
just some of the mechanisms that remain partially unclear 
and therefore require further investigation to help the 
Fig. 3 Scheme of the molecular mechanisms that systematic exposure to cigarette smoke can influence during carcinogenesis of the mammary 
gland. Different components of cigarette smoke can induce mechanisms, at transcriptional level, that promote the expression of anti‑apoptotic and 
mitotic checkpoints genes. Solid lines indicate a mechanism or pathway established experimentally. Dashed lines indicate a mechanism or pathway 
not determined yet. Arrowheads indicate upregulation and flattened heads indicate downregulation
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integration of the molecular models that explain the inter-
vention of high risk habits in transcriptional regulation 
during carcinogenesis of breast tissue.
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